Rapid knockout and reporter mouse line generation and breeding colony establishment using EUCOMM conditional-ready embryonic stem cells: A case study

Frontiers in Endocrinology

Volumn 6, Issue JUN, 2015, Pages

  Coleman, James L J ^a,b   Brennan, Karen ^a   Ngo, Tony ^a,b   Balaji, Poornima ^a,b   Graham, Robert M ^a,b   Smith, Nicola J ^a,b  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

C57BL 6; Conditional knockout; Cre recombinase; EUCOMM; Flp recombinase; Inducible knockout; Mouse model

Indexed keywords

BETA GALACTOSIDASE; CRE RECOMBINASE; TAMOXIFEN;

ALGORITHM; ANIMAL WELFARE; ARTICLE; BREEDING; CRISPR CAS SYSTEM; CRYOPRESERVATION; EMBRYONIC STEM CELL; GENE MUTATION; GENE TARGETING; GERMLINE STEM CELL; IMMUNOHISTOCHEMISTRY; KARYOTYPE; KNOCKOUT MOUSE; NONHUMAN; PHENOTYPE; TRANSGENIC MOUSE;

EID: 84936770899     PISSN: None     EISSN: 16642392     Source Type: Journal    
DOI: 10.3389/fendo.2015.00105     Document Type: Article

References (42)

1. Suckow MA, Danneman P, Brayton C. First ed. In: Suckow MA, editor. The Laboratory Mouse. CRC Press (2001). p. 1-5.
2. Capecchi MR. Gene targeting in mice: functional analysis of the mammalian genome for the twenty-first century. Nat Rev Genetics (2005) 6(6):507-12. doi:10.1038/nrg1619
3. International Mouse Knockout Consortium, Collins FS, Rossant J, Wurst W. A mouse for all reasons. Cell (2007) 128(1):9-13. doi:10.1016/j.cell.2006.12.018
4. Bradley A, Anastassiadis K, Ayadi A, Battey JF, Bell C, Birling MC, et al. The mammalian gene function resource: the international knockout mouse consortium. Mamm Genome (2012) 23(9-10):580-6. doi:10.1007/s00335-012-9422-2
5. Skarnes WC, Rosen B, West AP, Koutsourakis M, Bushell W, Iyer V, et al. A conditional knockout resource for the genome-wide study of mouse gene function. Nature (2011) 474(7351):337-42. doi:10.1038/nature10163
6. Seymour PA, Sander M. Immunohistochemical detection of beta-galactosidase or green fluorescent protein on tissue sections. Methods Mol Biol (2007) 411:13-23. doi:10.1007/978-1-59745-549-7_2
7. Beermann S, Seifert R, Neumann D. Commercially available antibodies against human and murine histamine H(4)-receptor lack specificity. Naunyn Schmiedebergs Arch Pharmacol (2012) 385(2):125-35. doi:10.1007/s00210-011-0700-4
8. Hafko R, Villapol S, Nostramo R, Symes A, Sabban EL, Inagami T, et al. Commercially available angiotensin II At(2) receptor antibodies are nonspecific. PLoS One (2013) 8(7):e69234. doi:10.1371/journal.pone.0069234
9. Herrera M, Sparks MA, Alfonso-Pecchio AR, Harrison-Bernard LM, Coffman TM. Lack of specificity of commercial antibodies leads to misidentification of angiotensin type 1 receptor protein. Hypertension (2013) 61(1):253-8. doi:10.1161/HYPERTENSIONAHA.111.00982
10. Schwenk F, Baron U, Rajewsky K. A cre-transgenic mouse strain for the ubiquitous deletion of loxP-flanked gene segments including deletion in germ cells. Nucleic Acids Res (1995) 23(24):5080-1. doi:10.1093/nar/23.24.5080
11. Rodriguez CI, Buchholz F, Galloway J, Sequerra R, Kasper J, Ayala R, et al. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet (2000) 25(2):139-40. doi:10.1038/75973
12. Crawley JN, Belknap JK, Collins A, Crabbe JC, Frankel W, Henderson N, et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (1997) 132(2):107-24. doi:10.1007/s002130050327
13. Mouse Genome Sequencing Consortium, Waterston RH, Lindblad-Toh K, Birney E, Rogers J, Abril JF, et al. Initial sequencing and comparative analysis of the mouse genome. Nature (2002) 420(6915):520-62. doi:10.1038/nature01262
14. Lusis AJ, Yu J, Wang SS. The problem of passenger genes in transgenic mice. Arterioscler Thromb Vasc Biol (2007) 27(10):2100-3. doi:10.1161/ATVBAHA.107.147918
15. Pettitt SJ, Liang Q, Rairdan XY, Moran JL, Prosser HM, Beier DR, et al. Agouti C57BL/6N embryonic stem cells for mouse genetic resources. Nat Methods (2009) 6(7):493-5. doi:10.1038/nmeth.1342
16. Brennan K. Colony management. First ed. In: Pease S, Saunders TL, editors. Advanced Protocols for Animal Transgenesis. Berlin: Springer (2011). p. 535-76.
17. Freeman HC, Hugill A, Dear NT, Ashcroft FM, Cox RD. Deletion of nicotinamide nucleotide transhydrogenase: a new quantitive trait locus accounting for glucose intolerance in C57BL/6J mice. Diabetes (2006) 55(7):2153-6. doi:10.2337/db06-0358
18. Huang TT, Naeemuddin M, Elchuri S, Yamaguchi M, Kozy HM, Carlson EJ, et al. Genetic modifiers of the phenotype of mice deficient in mitochondrial superoxide dismutase. Hum Mol Genet (2006) 15(7):1187-94. doi:10.1093/hmg/ddl034
19. Mattapallil MJ, Wawrousek EF, Chan CC, Zhao H, Roychoudhury J, Ferguson TA, et al. The Rd8 mutation of the Crb1 gene is present in vendor lines of C57BL/6N mice and embryonic stem cells, and confounds ocular induced mutant phenotypes. Invest Ophthalmol Vis Sci (2012) 53(6):2921-7. doi:10.1167/iovs.12-9662
20. Matsuo N, Takao K, Nakanishi K, Yamasaki N, Tanda K, Miyakawa T. Behavioral profiles of three C57BL/6 substrains. Front Behav Neurosci (2010) 4:29. doi:10.3389/fnbeh.2010.00029
21. Simon MM, Greenaway S, White JK, Fuchs H, Gailus-Durner V, Wells S, et al. A comparative phenotypic and genomic analysis of C57BL/6J and C57BL/6N mouse strains. Genome Biol (2013) 14(7):R82. doi:10.1186/gb-2013-14-7-r82
22. White JK, Gerdin AK, Karp NA, Ryder E, Buljan M, Bussell JN, et al. Genome-wide generation and systematic phenotyping of knockout mice reveals new roles for many genes. Cell (2013) 154(2):452-64. doi:10.1016/j.cell.2013.06.022
23. Hayashi S, McMahon AP. Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation/inactivation in the mouse. Dev Biol (2002) 244(2):305-18. doi:10.1006/dbio.2002.0597
24. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest (2005) 115(4):1092-9. doi:10.1172/JCI200523378
25. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A (2006) 103(47):17985-90. doi:10.1073/pnas.0605545103
26. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, et al. AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab (2011) 13(4):469-75. doi:10.1016/j.cmet.2011.03.001
27. Li H, Weatherford ET, Davis DR, Keen HL, Grobe JL, Daugherty A, et al. Renal proximal tubule angiotensin AT1A receptors regulate blood pressure. Am J Physiol Regul Integr Comp Physiol (2011) 301(4):R1067-77. doi:10.1152/ajpregu.00124.2011
28. Thyagarajan B, Guimaraes MJ, Groth AC, Calos MP. Mammalian genomes contain active recombinase recognition sites. Gene (2000) 244(1-2):47-54. doi:10.1016/S0378-1119(00)00008-1
29. Huh WJ, Mysorekar IU, Mills JC. Inducible activation of Cre recombinase in adult mice causes gastric epithelial atrophy, metaplasia, and regenerative changes in the absence of "floxed" alleles. Am J Physiol Gastrointest Liver Physiol (2010) 299(2):G368-80. doi:10.1152/ajpgi.00021.2010
30. Jeannotte L, Aubin J, Bourque S, Lemieux M, Montaron S, Provencher St-Pierre A. Unsuspected effects of a lung-specific Cre deleter mouse line. Genesis (2011) 49(3):152-9. doi:10.1002/dvg.20720
31. Bersell K, Choudhury S, Mollova M, Polizzotti BD, Ganapathy B, Walsh S, et al. Moderate and high amounts of tamoxifen in alphaMHC-MerCreMer mice induce a DNA damage response, leading to heart failure and death. Dis Model Mech (2013) 6(6):1459-69. doi:10.1242/dmm.010447
32. Lexow J, Poggioli T, Sarathchandra P, Santini MP, Rosenthal N. Cardiac fibrosis in mice expressing an inducible myocardial-specific Cre driver. Dis Model Mech (2013) 6(6):1470-6. doi:10.1242/dmm.010470
33. Pham CT, MacIvor DM, Hug BA, Heusel JW, Ley TJ. Long-range disruption of gene expression by a selectable marker cassette. Proc Natl Acad Sci U S A (1996) 93(23):13090-5. doi:10.1073/pnas.93.23.13090
34. Fiering S, Epner E, Robinson K, Zhuang Y, Telling A, Hu M, et al. Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev (1995) 9(18):2203-13. doi:10.1101/gad.9.18.2203
35. Cotton LM, Meilak ML, Templeton T, Gonzales JG, Nenci A, Cooney M, et al. Utilising the resources of the international knockout mouse consortium: the Australian experience. Mamm0020Genome (2015) 26(3-4):142-53. doi:10.1007/s00335-015-9555-1
36. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, et al. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res (2001) 89(1):20-5. doi:10.1161/hh1301.092687
37. Dalton R. New Orleans researchers fight to salvage work from submerged labs. Nature (2005) 437:300. doi:10.1038/437300a
38. Abbott A. Animal-rights activists wreak havoc in Milan laboratory. Nature (2013). doi:10.1038/nature.2013.12847
39. Hsu PD, Lander ES, Zhang F. Development and applications of CRISPR-Cas9 for genome engineering. Cell (2014) 157(6):1262-78. doi:10.1016/j.cell.2014.05.010
40. Sander JD, Joung JK. CRISPR-Cas systems for editing, regulating and targeting genomes. Nat Biotechnol (2014) 32(4):347-55. doi:10.1038/nbt.2842
41. Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, et al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol (2013) 31(9):822-6. doi:10.1038/nbt.2623
42. Carroll D. Genome engineering with targetable nucleases. Annu Rev Biochem (2014) 83:409-39. doi:10.1146/annurev-biochem-060713-035418